cinvanti

Generic: aprepitant

Labeler: heron therapeutics, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name cinvanti
Generic Name aprepitant
Labeler heron therapeutics, inc.
Dosage Form INJECTION, EMULSION
Routes
INTRAVENOUS
Active Ingredients

aprepitant 130 mg/18mL

Manufacturer
Heron Therapeutics, Inc.

Identifiers & Regulatory

Product NDC 47426-201
Product ID 47426-201_276ea381-d554-4e61-8511-39e6fd8291d6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA209296
Listing Expiration 2026-12-31
Marketing Start 2018-01-03

Pharmacologic Class

Established (EPC)
substance p/neurokinin-1 receptor antagonist [epc]
Mechanism of Action
neurokinin 1 antagonists [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 47426201
Hyphenated Format 47426-201

Supplemental Identifiers

RxCUI
1995150 1995155
UNII
1NF15YR6UY
NUI
N0000010262 N0000175786 N0000182141 N0000185507 N0000185506

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cinvanti (source: ndc)
Generic Name aprepitant (source: ndc)
Application Number NDA209296 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 130 mg/18mL
source: ndc
Packaging
  • 1 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS
source: ndc

Packages (1)

47426-201-01 1 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS

Ingredients (1)

aprepitant (130 mg/18mL)

Linked Drug Pages (1)

CINVANTI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "276ea381-d554-4e61-8511-39e6fd8291d6", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["1995150", "1995155"], "spl_set_id": ["4c218d3a-a508-4abc-9ed8-a6e8e191d1b4"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Heron Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (47426-201-01)  / 18 mL in 1 VIAL, GLASS", "package_ndc": "47426-201-01", "marketing_start_date": "20180103"}], "brand_name": "CINVANTI", "product_id": "47426-201_276ea381-d554-4e61-8511-39e6fd8291d6", "dosage_form": "INJECTION, EMULSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "47426-201", "generic_name": "aprepitant", "labeler_name": "Heron Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CINVANTI", "active_ingredients": [{"name": "APREPITANT", "strength": "130 mg/18mL"}], "application_number": "NDA209296", "marketing_category": "NDA", "marketing_start_date": "20180103", "listing_expiration_date": "20261231"}